NCT07519564 2026-04-09
A Phase I Clinical Study to Evaluate the PK, PD, Efficacy, and Safety of GB18 Injection in Patients With Tumor Cachexia
Kexing Biopharm Co., Ltd.
Phase 1 Not yet recruiting
Kexing Biopharm Co., Ltd.
Second Xiangya Hospital of Central South University
AVEO Pharmaceuticals, Inc.
Genfleet Therapeutics (Shanghai) Inc.